Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial An increasing number of ...
*M.R. and F.M.-B. were expert panel cochairs. D.C. and A.J. contributed equally to this work. An increasing number of therapies are approved to treat cancers harboring specific genomic biomarkers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback